South Dakota Targets Adolescent Addiction as $7.8 Million Opioid Settlement Funds Flow to 10 Organizations

South Dakota awarded $7.8 million in opioid settlement funds to ten organizations Thursday, with the state's largest single grant—$3 million to Avera Behavioral Health—designated specifically for expanding adolescent addiction treatment programs. The allocation represents the second round of what state officials call "transformative grants" under a revamped funding framework designed to address what Governor Larry Rhoden described as the state's "opportunity and obligation to invest these dollars wisely."

Speaking at the announcement in downtown Sioux Falls, Rhoden acknowledged South Dakota's relatively strong position compared to many states: "We have the 2nd lowest overdose death rate in America," he noted, before adding the caveat that shapes much of the state's current addiction policy thinking, "but we can always do better." That determination to move beyond complacency appears to be driving both the structure and the priorities behind this latest funding distribution, which deliberately targets gaps in the state's treatment continuum rather than simply reinforcing existing programs.

The $3 million Avera Behavioral Health received—by far the largest award in this round—will fund expansion of the organization's adolescent addiction treatment capacity. Thomas Otten, Avera's Vice President, pointed to research indicating that "over 90% of adults with substance use disorders began their addiction as teenagers" to justify the focus on youth intervention. The logic is straightforward: catching addiction early, before it hardens into decades-long patterns of use and relapse, offers better odds of sustained recovery than attempting intervention after years of progression. Yet adolescent treatment programs remain relatively scarce across South Dakota and much of the rural United States, where treatment infrastructure tends to prioritize adult services and where the specialized clinical expertise required to work effectively with adolescent populations—distinct developmental needs, family systems involvement, educational continuity considerations—proves difficult to recruit and retain in communities outside major urban centers.

Avera plans to use the funding to extend services to what the organization describes as "a wider range of young people struggling with addiction," though specifics about whether that means expanded geographic reach, additional bed capacity, more intensive outpatient programs, or some combination remain to be clarified as implementation details emerge. What's clear is that South Dakota officials view adolescent treatment expansion as central to any meaningful long-term reduction in the state's addiction burden, even as the state celebrates maintaining one of the nation's lowest overdose mortality rates—a statistic that, while accurate, also reflects South Dakota's relatively small population and specific demographic characteristics that don't necessarily predict future trends as fentanyl continues spreading into regions previously less affected by synthetic opioids.

The second-largest grant—$500,000 to Emily's Hope—takes a different approach by funding prevention rather than treatment. Angela Kennecke, the organization's founder and CEO, explained that the funds will support expanding addiction prevention curriculum into K-12 classrooms across South Dakota. "We're excited about it. It's about protecting their bodies and minds, and equipping them with the skills to deal with challenges," Kennecke said, framing the program as teaching both factual information about substance use risks and practical coping strategies for managing emotional pressures without turning to drugs or alcohol.

Prevention programs face inherent challenges in demonstrating effectiveness—it's difficult to measure the addiction that didn't happen—yet the logic of early intervention through education remains broadly appealing to policymakers, school administrators, and parents. Whether classroom-based prevention curricula actually reduce adolescent substance use rates over time remains debated within addiction research circles, with some studies showing modest effects while others find minimal impact beyond short-term knowledge gains. The most effective prevention programs tend to be intensive, sustained over multiple years, and integrated into broader school-based mental health support systems rather than delivered as one-off presentations or brief curriculum units. How Emily's Hope will structure its expanded programming, and whether the organization has the capacity to deliver the kind of sustained, developmentally appropriate prevention education that research suggests works, will determine whether the $500,000 investment translates into measurable reductions in adolescent substance use initiation rates years down the line.

Beyond Avera and Emily's Hope, the remaining eight grants fund an intentionally diverse mix of initiatives that state officials describe as building out a more complete "system of care" across South Dakota. One grant will establish a mobile street medicine clinic, bringing healthcare directly to individuals experiencing homelessness and addiction who rarely access traditional treatment facilities. Another funds training programs to help primary care physicians incorporate addiction treatment into general medical practice, addressing the reality that most people with substance use disorders never reach specialized addiction treatment centers but do see primary care doctors for other health concerns—creating opportunities for screening, brief intervention, and medication-assisted treatment initiation if primary care providers have the training and confidence to offer those services.

A third grant category funds recovery coaching specifically for incarcerated individuals and people recently released from jail or prison. The logic here reflects growing recognition that the period immediately following release from incarceration represents extremely high risk for fatal overdose—tolerance drops during abstinence behind bars, many people return to drug use shortly after release using the same amounts they did before incarceration, and the combination frequently proves lethal. Recovery coaches can help navigate the chaotic period following release, connecting people to treatment, housing, employment support, and the practical assistance that makes sustained recovery feasible rather than abstractly possible.

What distinguishes South Dakota's current approach from typical opioid settlement spending patterns—which vary wildly across states and municipalities, with some jurisdictions making strategic investments in evidence-based treatment expansion while others spend settlement funds on police equipment, highway beautification, or other projects with minimal connection to addiction treatment or overdose prevention—is the deliberate focus on system gaps rather than simply distributing funds to existing organizations based on historical relationships or political connections.

Secretary of the South Dakota Department of Social Services Matt Althoff emphasized that structural design during Thursday's announcement: "We did everything we could to make this a low threshold to show interest. We went looking for where the true gaps are and how they can be measured and filled." That approach—identifying deficits in the treatment continuum, then soliciting proposals specifically designed to address those deficits—represents more strategic planning than many states have demonstrated with settlement funds, though implementation will determine whether the framework actually delivers improved outcomes or simply creates another layer of administrative process without fundamentally changing treatment access for South Dakotans struggling with addiction.

The $7.8 million distributed Thursday represents what officials described as "the second round of 'transformative grants'"—awards of up to $2 million each—since South Dakota restructured its opioid settlement funding system to create multiple tiers of grants. The tiered structure appears designed to balance large-scale infrastructure investments (like Avera's adolescent program expansion) with smaller, more targeted initiatives that address specific gaps (like primary care addiction training) while maintaining flexibility to fund innovative approaches that don't fit traditional treatment service categories.

Nationally, opioid settlement funds continue flowing to state and local governments as part of agreements exceeding $50 billion over two decades, with pharmaceutical distributors, pharmacy chains, and manufacturers paying settlements related to their roles in the overdose epidemic. How effectively those billions translate into expanded treatment capacity, harm reduction programming, prevention initiatives, and ultimately reduced overdose mortality remains highly variable across jurisdictions. Some counties have made strategic investments in medication-assisted treatment expansion, naloxone distribution, and evidence-based interventions with demonstrated effectiveness. Others have diverted settlement funds toward law enforcement equipment purchases, general budget gaps, or projects with questionable connections to addressing addiction or preventing overdose deaths.

South Dakota's emphasis on adolescent treatment, prevention education, mobile crisis response, and primary care integration suggests officials understand that reversing addiction trends requires intervention across multiple points—catching some people before substance use begins, reaching others early in their addiction trajectory, and providing multiple pathways into treatment for those with established substance use disorders. Whether the state's "deliberate build-out of a more complete system of care," as officials described the strategy, actually creates that continuum or simply funds disconnected programs that never cohere into integrated services will depend heavily on coordination mechanisms, data collection to track outcomes, and willingness to adjust or defund initiatives that prove ineffective.

The oversight question matters because opioid settlement funds represent a one-time windfall rather than sustainable annual appropriations. Once the $7.8 million distributed Thursday gets spent over the coming years, those programs will need alternative funding sources to continue operations—state general funds, Medicaid reimbursement for billable services, philanthropic support, participant fees, or some combination. Programs designed to be self-sustaining through insurance reimbursement stand better long-term viability prospects than those dependent on continued grant funding that may or may not materialize after settlement money runs out. Whether South Dakota officials structured these grants with sustainability in mind, or primarily focused on launching new initiatives without clear plans for continuation funding, will become apparent over the next several years as programs either secure alternative revenue streams or face closure when settlement funds exhaust.

For now, the ten organizations receiving grants face the immediate challenge of building or expanding programs in a state where addiction treatment infrastructure remains sparse outside Sioux Falls and Rapid City. Recruiting qualified staff, navigating licensing requirements, establishing protocols, coordinating with existing providers, and actually reaching the populations they propose to serve will determine whether South Dakota's strategic framework translates into meaningful increases in treatment access and, ultimately, measurable reductions in addiction-related harms beyond the relatively low baseline the state currently maintains. The framework looks promising on paper; whether it delivers results for South Dakotans struggling with substance use disorders depends on implementation details that can't be judged from funding announcements and political speeches.